Clinical Trial Update: Safety Study of HBV-002 West Nile Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 safety study of HBV-002 West Nile Vaccine in healthy adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• West Nile Virus Disease

Drugs mentioned

• HBV-002 West Nile Vaccine

Snippet

Sponsor: Hawaii Biotech, Inc. | Conditions: West Nile Virus Disease | Phase 1 | Status: COMPLETED